Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,524
Sort by:
Tinnitus - Pipeline Review, H1 2020
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
45 pages
Esophageal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Esophageal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Esophageal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1342 pages
Thyroid Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Thyroid Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Thyroid Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
885 pages
Bacterial Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
34 pages
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Peripheral Neuropathy (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
151 pages
Gastric Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastric Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastric Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
53 pages
Pancreatitis - Pipeline Review, H1 2020
US$ 2,000.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pancreatitis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Pancreatitis (Gastrointestinal) The guide covers the ...
March 2020
101 pages
Premature Labor (Tocolysis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Premature Labor (Tocolysis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Labor (Tocolysis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
53 pages
Rhabdomyosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rhabdomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rhabdomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
421 pages
Rhinovirus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rhinovirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rhinovirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
58 pages
Polycystic Ovarian Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
51 pages
Axillary Hyperhidrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
53 pages
Alcoholic Hepatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
101 pages
Contact Dermatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
43 pages
Hand, Foot and Mouth Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
46 pages
Retinopathy Of Prematurity - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Arterial Thrombosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
60 pages
Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
147 pages
Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
75 pages
Oligodendroglioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oligodendroglioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oligodendroglioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
156 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Proliferative Diabetic Retinopathy (PDR) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Sinusitis - Pipeline Review, H1 2020
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
117 pages
Schistosomiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Schistosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
42 pages
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Resistant Pseudomonas aeruginosa Infections (Infectious Disease), complete with analysis by stage of development ...
March 2020
58 pages
Uveal Melanoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
312 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
114 pages
Drug Overdose - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
79 pages
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ebolavirus Infections (Ebola Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
300 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
283 pages
Heavy Metal Poisoning - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
38 pages
Hypopharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
336 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
250 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
186 pages
Influenzavirus B Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
160 pages
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Malignant Pleural Effusion - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
49 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
102 pages
Fragile X Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
188 pages
Liver Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
69 pages
Achondroplasia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
60 pages
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020 SUMMARY 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target constitutes close to 9 molecules. Out of...
March 2020
52 pages
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020'; 5-Hydroxytryptamine Receptor...
March 2020
61 pages
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H1 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H1 2020 SUMMARY 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - 5-HT7 receptor is a member of the GPCR superfamily...
March 2020
74 pages
Actinic (Solar) Keratosis - Pipeline Review, H1 2020
US$ 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Actinic (Solar) Keratosis - Pipeline Review, H1 2020,...
March 2020
66 pages
Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020 SUMMARY Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Aryl hydrocarbon receptor is a protein encoded...
March 2020
113 pages
C-C Chemokine Receptor Type 4 - Pipeline Review, H1 2020
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Pipeline Review, H1 2020 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is...
March 2020
65 pages
Calcitonin Gene Related Peptide - Pipeline Review, H1 2020
US$ 3,500.00
Calcitonin Gene Related Peptide - Pipeline Review, H1 2020 SUMMARY Calcitonin Gene Related Peptide (CGRP) pipeline Target constitutes close to 10 molecules. The latest report Calcitonin Gene Related...
March 2020
81 pages
